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Abstract
Background: Structural variation (SV) influences genome organization and contributes to human disease. However,
the complete mutational spectrum of SV has not been routinely captured in disease association studies.
Results: We sequenced 689 participants with autism spectrum disorder (ASD) and other developmental abnormalities
to construct a genome-wide map of large SV. Using long-insert jumping libraries at 105X mean physical coverage and
linked-read whole-genome sequencing from 10X Genomics, we document seven major SV classes at ~5 kb SV
resolution. Our results encompass 11,735 distinct large SV sites, 38.1% of which are novel and 16.8% of which
are balanced or complex. We characterize 16 recurrent subclasses of complex SV (cxSV), revealing that: (1) cxSV are
larger and rarer than canonical SV; (2) each genome harbors 14 large cxSV on average; (3) 84.4% of large cxSVs
involve inversion; and (4) most large cxSV (93.8%) have not been delineated in previous studies. Rare SVs are
more likely to disrupt coding and regulatory non-coding loci, particularly when truncating constrained and
disease-associated genes. We also identify multiple cases of catastrophic chromosomal rearrangements known as
chromoanagenesis, including somatic chromoanasynthesis, and extreme balanced germline chromothripsis events
involving up to 65 breakpoints and 60.6 Mb across four chromosomes, further defining rare categories of extreme cxSV.
Conclusions: These data provide a foundational map of large SV in the morbid human genome and demonstrate
a previously underappreciated abundance and diversity of cxSV that should be considered in genomic studies of
human disease.
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Background
Structural variation (SV), or the rearrangement of
chromosomal segments (≥50 bp), is a major driver of the
organization and content of individual genomes [1]. SV
manifests in multiple mutational forms, canonically cate-
gorized as “balanced” SV—rearrangements lacking major
gain or loss of genomic DNA, such as inversions, multiple
classes of insertions, and translocations—and “unbalanced”
SV, or copy number variants (CNV), which involve changes
in DNA dosage [2, 3]. Recent research has demonstrated
that some rearrangements have multiple, compounded
mutational signatures and do not fit into a single canonical
SV category [4–9]. These non-canonical, complex SVs
(cxSV) span a heterogeneous range from relatively simple
CNV-flanked inversions to extreme rearrangements involv-
ing dozens of loci across multiple chromosomes [4, 10].
The most severe cxSVs are thought to involve sudden
chromosome pulverization and reorganization; this group
of ultra-rare, catastrophic cxSVs are known collectively as
chromoanagenesis [11], which encompasses three core pro-
posed mechanisms: chromothripsis [12]; chromoanasynth-
esis [13]; and chromoplexy [14]. The most commonly
reported of these, chromothripsis, was first observed in
cancer with interspersed deletion bridges between frag-
ments of derivative chromosomes [12, 15, 16], while subse-
quent studies discovered both balanced and unbalanced
forms of chromothripsis in the human germline [9, 10, 17,
18]. Though less frequently reported, chromoanasynthesis
and chromoplexy have also been observed in the human
germline [9, 13, 19–23]. Despite these discoveries, the pat-
terns, rates, and properties of cxSVs have primarily been
the focus of cancer genomics and such rearrangements
remain largely underappreciated in the human germline.
Recent studies have begun to profile SV at sequence
resolution in healthy human populations, such as the
1000 Genomes Project and the Genome of the Netherlands
Consortium [1, 24], though most population-scale stud-
ies to date have not deeply characterized balanced SVs
or cxSVs. Indeed, while somatic cxSV has been an
emphasis in analyses of tumor genomes [25–27], inves-
tigations of SV in germline disease have predominantly
been restricted to gross chromosomal abnormalities
and large, de novo CNVs [9, 28–36]. Several studies of
germline SV have demonstrated that a subset of SV
represents an important class of penetrant, pathogenic
loss-of-function (LoF) mutations that are not broadly
ascertained in human disease studies [4, 5, 37–39]. By
example, imputed genotypes of polymorphic SVs at the
major histocompatibility complex (MHC) and hapto-
globin (HP) loci in large populations have demon-
strated disease relevance for schizophrenia and
untoward cardiovascular lipid phenotypes, respectively
[40, 41]. To date, no population-scale disease studies
have evaluated the full mutational spectrum of large
SV—specifically including balanced SV and cxSV—though
there is a pressing need for such SV maps with the
upcoming emergence of large-scale whole-genome se-
quencing (WGS) studies to characterize the genetic archi-
tecture of human disease.
Here, we performed long-insert whole-genome se-
quencing (liWGS) on 689 participants diagnosed with
autism spectrum disorder (ASD) or other developmental
disorders to benchmark the population-level landscape
of complex and large SVs in a relevant disease cohort.
liWGS is optimized to provide deep physical coverage
(mean 105X) by large fragments (mean 3.5 kb) capable
of detecting large SVs, including some variants that may
be intractable to standard short-insert WGS (siWGS)
due to repetitive sequences and microhomology that
often mediate SV breakpoints, with the primary limita-
tion being its comparatively limited effective resolution
(~5 kb) [42, 43]. These data yielded a catalog of seven
major SV classes and further revealed 16 recurrent sub-
classes of cxSV, most of which had not been classified in
human disease studies. Further analyses identified a sur-
prising abundance and diversity of inversion variation
and derived a broad spectrum of rare cxSV in every gen-
ome surveyed, which collectively displayed many of the
hallmarks of deleterious biological significance and evo-
lutionary selection. This study also detected three cases
of extreme germline chromoanagenesis, which were in-
tegrated into an analysis of all previously reported cases
of chromoanagenesis in the literature to define the prop-
erties of germline chromoanagenesis. These data pro-
vided an initial atlas of SV in the morbid germline that
can be used as a benchmarking resource for future in-
vestigations and suggest that balanced SV and cxSV are
relatively common in the human genome, warranting
consideration in genetic studies of disease.
Results
Sample selection and genome sequencing
We selected 686 participants diagnosed with idiopathic
ASD from the Simons Simplex Collection (SSC) [44]. All
participants from the SSC met standardized diagnostic
criteria for ASD and many included co-morbid diagno-
ses of intellectual disability, developmental delay, or
seizures. All participants had two unaffected parents and
at least one unaffected sibling available from the SSC.
Independently, we recruited three unrelated participants
presenting with neurodevelopmental disorders (NDD) or
congenital anomalies and a de novo translocational in-
sertion ascertained by clinical karyotyping that appeared
to harbor additional complexity. We performed liWGS
on all 689 participants to a mean insert size of 3.5 kb
and a mean physical coverage of 105X as shown in
Fig. 1a and b [42, 43].
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Discovery and validation of a diverse spectrum of SV in
the morbid human genome
Among the initial 686 SSC participants, analyses re-
vealed a highly heterogeneous landscape of 11,735 dis-
tinct SVs at the resolution of liWGS, representing a total
of 436,741 SV observations or a mean of 637 large SVs
per genome (Additional file 1 and Fig. 1c and d). Exten-
sive validation was performed to evaluate the SV detec-
tion methods used: one-third of all fully resolved SVs
(33.8%; 3756/11,108) were assessed using a combination
of five orthogonal approaches, as detailed in Additional
file 2: Supplemental Results 1 and Supplemental Table 1.
These experiments estimated a global false discovery
rate (FDR) of 10.6% and false negative rate (FNR) of
5.9% for SV discovery from liWGS. Performance was
best for cxSVs (2.6% FDR; see Additional file 2: Supple-
mental Note 1) and canonical deletions (5.3% FDR), which
collectively comprised the majority (57.4%) of all SVs. As
anticipated, validation rates were lowest for insertions
(22.9% FDR), the majority of which are known to be
smaller than the resolution of liWGS (e.g. SVA and Alu
mobile element insertions) [1, 7, 45] and represent a major
challenge for liWGS detection. Excluding this category of
variation, the overall FDR improved to 9.1%. Importantly,
16.8% (1968/11,735) of all SVs were either balanced or
complex, emphasizing that an appreciable fraction of large
SV per genome is overlooked when restricting analyses to
canonical CNVs alone. These analyses also found that
10.9% (75/686) of all participants harbored at least one very
large, rare SV (≥1 Mb; variant frequency (VF) < 1%), impli-
cating rare SV as a frequent source of large structural diver-
gence between individual genomes (Fig. 1e and f).
Novel SV sites and rearrangement complexity
This SV map was compared with six recent WGS SV
studies outside of the SSC [1, 5, 7, 46–48], the Database of
Genomic Variants (DGV) [49], and the InvFEST inversion
database [50], which determined that 38.1% (4233/11,108)
of all SVs detected in this study (excluding incompletely
resolved sites, n = 627/11,735) had not been previously re-
ported. This was particularly true for cxSVs, nearly all
which were novel to this study (93.8%; 271/289), in-
cluding 50.2% for which at least one breakpoint had
been observed previously but likely misclassified as ca-
nonical SVs (e.g. Additional file 2: Figure S1). Notably,
97.4% of cxSVs were validated in the present study;
however, due to the limited resolution of liWGS we
predict that this is likely to be an underestimate of the
Fig. 1 The diverse landscape of SV in participants with ASD and other developmental disorders. We sequenced the genomes of 689 participants with
ASD and other developmental disorders. a Physical coverage and (b) median insert size of liWGS libraries. c Count and distributions of large SV detected
by liWGS (Additional file 1). d Distribution of SVs per participant by SV class. e Density plots of SV sizes by class. Characteristic Alu and L1 peaks are absent
due to the resolution of liWGS (> ~ 5 kb) being larger than most mobile element insertions. f Cumulative distributions of SV frequencies by class.
Singletons (single observation among all 686 samples) are marked with an arrow. Rare SVs are defined as those with variant frequency (VF) < 1%
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complexity associated with these variants and their
overall structure as liWGS is blind to micro-complexity
at SV breakpoints, and the resolution to delineate
components of cxSVs comprised of small variants (< 5 kb)
is limited (Additional file 2: Supplemental Note 1) [1, 10,
51, 52]. In sum, these data revealed that large cxSVs in
humans are substantially more abundant and diverse
than has been previously appreciated.
Defining and contrasting 16 distinct subclasses of large,
recurrent cxSV
The frequency of novel, large cxSVs in this cohort led us
to further characterize their mutational spectra. We ob-
served that 42.6% (123/289) of all cxSVs were poly-
morphic (i.e., appearing in at least two participants), and
each participant harbored a median of 14 large cxSVs
(range: 6–23 cxSVs per genome), establishing that cxSV is
a standing class of variation present in most, if not all,
human genomes. We classified 16 unique subclasses of re-
current and relatively common cxSVs for consideration in
future genomic studies, as presented in Fig. 2. Each cxSV
subclass appeared in at least five participants and featured
a signature variant allele structure. The majority of these
subclasses (10/16) were unbalanced inversions and thus
most cxSVs (84.8%) involved at least one inverted seg-
ment. Correspondingly, CNV-flanked inversions com-
prised the largest group of cxSVs (77.2%), with complex
duplications being larger and rarer on average than
complex deletions (Additional file 2: Figure S2). Both
deletions and duplications flanking complex inversions
were equally likely to arise at either inversion break-
point, consistent with either replicative repair-based
mechanisms such as MMBIR/FoSTeS [6, 39, 53] or syn-
chronous repair of multiple simultaneous double-
strand breaks [18, 54]. Most cxSVs were intrachromo-
somal, with relatively few rearrangements (3.1%; 9/289)
Fig. 2 Classifying 16 recurrent subclasses of large, complex SVs in the human genome. At liWGS resolution, we identified 16 recurrent classes of
cxSV, defined here as non-canonical rearrangements involving two or more distinct SV signatures or at least three linked breakpoints. We
validated 97.4% (150/154) of all cxSV sites assessed by at least one assay. Each participant harbored a median of 14 cxSVs at liWGS resolution (range:
6–23 cxSVs per participant). We identified 289 distinct cxSVs across 686 participants, totaling 9666 cxSV observations. Each row represents a subclass
of cxSV, with columns representing the subclass abbreviation, number of distinct variants discovered, validation rate, total number of observed variants
across all participants, the percentage of participants that were found to harbor at least one such variant in their genome, the median size of all variants
in that subclass, each subcomponent SV signature that comprises the class, a linear schematic of each class of cxSV, and a simulated
example of the copy-number profile as would be observed by chromosomal microarray or WGS
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involving two or more chromosomes. As discussed
above, these 16 cxSV subclasses certainly represent a
conservative initial catalog of the full complement
of cxSV in humans given the resolution of liWGS.
Abundance of canonical and complex inversion variation
Routine detection of large inversion variation has his-
torically been a challenge for high-throughput tech-
nologies, including siWGS [1, 50, 55–57]. Although
recent advances in long-read and strand-specific WGS
represent promising novel platforms for inversion dis-
covery [7, 58, 59], liWGS remains particularly well
suited for inversion detection as the distance spanned
between paired reads (~3.5 kb) avoids most confound-
ing repetitive sequences and imbalances that frequently
occur at inversion breakpoints [6, 10]. In this cohort,
liWGS identified a median of 87 inversion variants per
participant, a surprising fraction of which (12.6%; 11/
87) were complex (Additional file 2: Figure S3A). These
complex inversions were larger on average than canon-
ical inversions (Additional file 2: Figure S3B) and were
also significantly enriched in rare variants (VF < 1%):
75.9% of complex inversions were rare (186 rare/245
total), while only 43% of canonical inversions were rare
(169 rare/393 total) (p = 1.2 × 10–16), which suggests
that complex inversions might be under relatively in-
creased purifying selection. It is possible that this trend
may also be attributable in part to a correlation be-
tween SV frequency and average size [1], as larger in-
versions might be less viable in the germline either due
to increased deleterious consequences or by obstructing
recombination [60]. The number of inversions per gen-
ome identified in this study was approximately twofold
greater than estimates from the 1000 Genomes Project
from low-depth siWGS on 2504 samples [1]. Given the
validation rate for inversions (canonical inversion:
89.8%; complex inversion: 96.9%), we hypothesized that
this difference may be due to inversion breakpoints be-
ing enriched near longer repetitive sequences, which
might confound siWGS but would still be accessible to
liWGS. Indeed, we found that 87.6% of all inversion-
associated variants (both complex and canonical; n =
636) had one or both breakpoints within ±500 bp (i.e.
conservative liWGS breakpoint resolution) of a rela-
tively long (≥300bp) annotated repetitive sequence
[61], and both breakpoints were in proximity to long re-
petitive sequence for 54.9% of inversions. Both observa-
tions significantly deviated from the null distribution
from 1 million matched simulations (p < 1.0 × 10–6), as
shown in Additional file 2: Figure S3C. This included
inversion breakpoints in segmental duplications, des-
pite the limited power of short-read sequencing to de-
tect variation at these loci, consistent with previously
proposed mechanistic hypotheses of inversion formation
[58, 59, 62]. Collectively, the patterns of canonical and
complex inversions observed herein suggest that a sub-
stantial fraction of such variation may be preferentially ac-
cessible to sequencing technologies like liWGS that
provide long-range information on genome structure.
Resolving intractable rare cxSV with linked-read WGS
We performed linked-read WGS (lrWGS) from 10X Gen-
omics [63] to resolve large, rare cxSVs detected by liWGS
in three participants for which the liWGS delineated rear-
rangements that were not fully resolved by orthogonal
validation. We sequenced these three participants and two
parents to a median of 31.1X nucleotide coverage. From
these data, we resolved all breakpoints of each predicted
large cxSV, notably including a de novo complex
translocation in a participant with ASD that involved
550 kb of inverted sequence and three breakpoints pre-
dicted by liWGS, two of which could not be validated
by traditional approaches (polymerase chain reaction
(PCR) and Sanger) or by siWGS due to low sequence
uniqueness flanking the junctions (Fig. 3). All three
breakpoints were confirmed and phased by 104 inde-
pendent lrWGS molecules, revealing disruption of the
genes PARK2 and CAMKMT. The other two large
cxSVs validated by lrWGS are provided in Additional
file 2: Figures S4 and S5. Building upon our earlier
observations of inversion variation, these data fur-
ther suggest that technologies that provide long-range
structural information will be of value for resolving
large complex chromosomal abnormalities, and com-
prehensive analyses are required in larger samples to
determine the improved yield of SVs from lrWGS as
compared to siWGS, liWGS, or other emerging
technologies.
Rare SVs exhibit multiple hallmarks of deleterious
biological consequences
Consistent with trends observed among rare coding
point mutations [64–67], rare SVs (VF < 1%) appeared to
be considerably more deleterious than common poly-
morphic SVs (VF > 1%) based on computational annota-
tions (Additional file 2: Supplemental Results 2). Rare
SVs in this cohort were larger than common SV, in line
with observations from the 1000 Genomes Project [1],
and were also nearly twice as likely to disrupt multiple
classes of regulatory non-coding elements, and 1.5-fold
more likely to result in predicted LoF of genes (all com-
parisons were significant and test statistics are provided
in Fig. 4a and b and Additional file 2: Table S2). The set
of genes truncated by rare LoF SVs in this study was also
approximately twofold enriched in disease-associated
genes [68–70], genes intolerant to functional mutation
[65–67], and genes with burdens of exonic deletions in
NDDs [38] (Fig. 4c and Additional file 2: Table S3.) These
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Fig. 3 liWGS and lrWGS resolved a de novo gene-disrupting cxSV that was cryptic to standard siWGS. We performed lrWGS from 10X Genomics
(Pleasanton, CA, USA) as a method of orthogonal validation for three large complex SVs detected by liWGS, two of which failed to fully validate
by traditional methods. One notable example is shown here; the other two are provided in Additional file 2: Figures S4 and S5. a A de novo complex
reciprocal translocation with three breakpoints between chromosomes 2 (pink) and 6 (green) was discovered by liWGS in a participant with ASD and
predicted to result in LoF of PARK2 and CAMKMT. However, two of three breakpoints (breakpoints #1 and #3; orange) were not detectable by siWGS.
b lrWGS heatmaps from Loupe software [113] analysis of lrWGS data showed clear evidence for each of the three SV breakpoints. c lrWGS resolved
and phased all three breakpoints, including both breakpoints that failed molecular validation due to low-complexity repetitive sequence (blue), which
were resolved by spanning the low-complexity sequence with 28 liWGS reads and 30 lrWGS molecules at breakpoint #1 and 12 liWGS reads and 41
lrWGS molecules at breakpoint #3
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findings were concordant with the hypothesis that loci
sensitive to disruptive point mutations in healthy individ-
uals would also show selective pressure against deleterious
SV. Finally, we identified ten specific loci that were signifi-
cantly enriched for rare SVs beyond genome-wide
expectations (Additional file 2: Supplemental Results 3,
Figure S6 and Tables S4–5), five of which involved genes
with evidence for roles in a broad spectrum of neuro-
logical disorders (PARK2, IMMP2L, CTNNA3, CYFIP1,
PTPRT) [32, 71–75]. Additional SV studies in larger
Fig. 4 Rare SVs are enriched for hallmarks of deleterious biological outcomes. Comparing all rare (VF < 1%) and common (VF > 1%) SVs discovered in this
cohort revealed differences in their respective functional annotations (Additional file 2: Table S2). a Rare SVs were larger on average than common SVs [1].
b Rare SVs were more likely than common SVs to disrupt genes, particularly when the disruption was predicted to result in LoF. Rare SVs were also more
likely than common SVs to result in disruption of promoters [112, 114], enhancers [112, 114], and TAD boundaries [110]. c Genes predicted to harbor
at least one LoF mutation due to a rare SV were enriched in many subcategories when compared to common SV, including genes predicted to be
constrained against truncating mutations in healthy individuals (Constrained) [65, 66], genes predicted to be intolerant of functional variation in healthy
individuals (Intolerant) [67], genes with significant burdens of exonic deletions in NDD cases versus healthy controls (NDD ExDels) [38], genes associated
with an autosomal dominant disorder (Autosomal Dom.) [68, 69], and genes with at least one pathogenic variant reported in ClinVar (Disease Assoc.) [70]
(Additional file 2: Table S3)
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matched case-control cohorts will be required to elucidate
any role of SV at these loci in disease risk, and such stud-
ies are ongoing.
Extreme chromoanagenesis in aberrant human
development
The most catastrophic SVs catalogued to date involve
the cxSV subclass known as chromoanagenesis. To
summarize existing knowledge of chromoanagenesis and
contextualize the findings from this study, we conducted
a literature review of published reports of germline chro-
moanagenesis at sequence resolution, almost all of which
arose de novo in affected individuals. The results of this
review are consolidated in Table 1 and Additional file 2:
Table S6 [9, 10, 13, 17–23, 76–78]. Based on this know-
ledge, and separate from the genome-wide SV analysis of
the 686 SSC participants described above, we performed
liWGS on an additional three unrelated participants
(participants TL010, UTR22, and TL009) with develop-
mental anomalies and large de novo translocational inser-
tions identified by clinical karyotyping, which we
suspected may represent more complex rearrangements.
The rearrangement in subject UTR22 has since been re-
cently described [9]. Sequencing analysis revealed that the
first two participants, TL010 and UTR22, harbored ex-
treme yet almost entirely balanced germline chromothrip-
sis events, each involving > 40 breakpoints, >40 Mb of
rearranged sequence, four chromosomes, and LoF of > 12
genes, yet < 1 Mb of total dosage imbalance (Fig. 5a and b,
Additional file 2: Table S7, and Additional file 3).
In contrast to the first two participants, TL009 har-
bored a somatic mosaic unbalanced chromoanasynthesis
of chromosome 19, involving 19.1 Mb of duplicated
DNA, copy gain (CG) of 567 genes, 361.2 kb of de-
leted DNA, and LoF of 12 additional genes (Fig. 5c
and Additional file 3). Intriguingly, while all eight du-
plicated loci arose on the maternal homologue, 6/8 of
these duplications were predicted to be mosaic from
liWGS (2.57 ± 0.02 copies, 95% confidence interval (CI)),
yet the other 2/8 duplications appeared at nearly three full
copies (2.93 ± 0.10 and 2.83 ± 0.09 copies, 95% CIs), which
may contrast previous assumptions that chromoanasynth-
esis arises in a single mutational process. Both of the ap-
parently higher-copy-state loci were significantly greater
in copy number than the six mosaic duplications (p =
3.60 × 10–12 and p = 9.18 × 10–8) but not different from
each other (p = 1.04 × 10–1) (Fig. 5d). Remarkably, these
two duplications were connected by a 5.1 Mb interstitial
inversion, resulting in a mutational signature that matches
the dupINVdup cxSV subclass previously described (Fig. 2)
[4]. We speculated that the rearrangement in TL009 may
have arisen initially as a de novo dupINVdup either in the
maternal germline or very early in embryonic develop-
ment, and was subsequently compounded by a second
mutational event, possibly through mitotic missegregation
driven by genome instability from the large dupINVdup
near the centromere (Additional file 2: Figure S7). These
three cases further illustrate that extreme chromothripsis
can arise in the germline while often resulting in near
dosage-neutral derivatives and that unbalanced chromoa-
nasynthesis can arise in soma, perhaps in a temporally
punctuated series of rearrangements more closely resem-
bling the compounded mutations of chromoplexy than a
single catastrophic mutational process [14, 79].
Table 1 Characteristics of chromoanagenesis classes
Chromothripsis Chromoanasynthesis Chromoplexy
Mutational event Single Single or multiple Single or multiple
Chromosomes Few (1–4) Few (usually 1) Many (usually≥ 4)
Breakpoints Many (≥5; sometimes > 25) Fewer (usually 5–25) Fewer (usually 5–25)
Breakpoint distribution Clustered Clustered Interspersed (usually in active
chromatin)
Breakpoint signature Blunt ends Microhomology Blunt ends
Dosage alteration Cancer: often unbalanced
(deletion bridges);
Germline: mainly balanced











Multiple DSBs during active
transcription + NHEJ
Proposed parent-of-origin bias Paternal None None
Proposed transmission bias Maternal None None
Germline reports 43 10 6
Case:Control 39:4 10:0 6:0
References [9, 10, 17, 18, 23, 76–78] [19–21] [9, 22, 23]
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Discussion
By applying an approach optimized for genome-wide SV
discovery to a cohort of nearly 700 participants with
ASD and related developmental disorders, these data
provided a glimpse of the diverse mutational landscape
of large SVs in the morbid human germline. Analyses
revealed a substantial number of novel canonical and
complex SV sites, and a wide breadth of large cxSV mu-
tational signatures. Ascertaining SVs with liWGS also
uncovered a surprising abundance of canonical and
complex inversion variation, some of which were likely
to be intractable to siWGS due to local sequence charac-
teristics in proximity to the breakpoints. Importantly,
owing to the limited resolution of liWGS, the barriers to
SV detection using short-read sequencing, and the limi-
tations of reference-based alignments more broadly [24],
the diversity of cxSVs described here still likely accounts
for only a fraction of the mutational landscape of cxSV
in the human germline, and likely underestimates the se-
quence-level complexity of the variants reported herein.
We anticipate many additional subclasses will continue to
be discovered from larger population-scale studies and
higher resolution technologies. Finally, annotation of the
balanced SVs and cxSVs identified in this cohort demon-
strated that these classes of variation contributed a modest
but meaningful number of perturbations of coding and
noncoding regulatory loci per genome, the effects of which
were predicted to be particularly deleterious among rare
variants, suggesting that routine characterization of the
complete spectrum of SV in genetic studies of human dis-
ease may improve power to resolve the genetic etiologies of
some disorders. In sum, these data thus represent a bench-
mark for major classes of large SVs that will be expanded
by future efforts.
These analyses indicate that large and complex
chromosomal abnormalities are relatively common in
the human germline, and that numerous large cxSVs
likely exist in every human genome, with the most ex-
treme cxSVs (e.g. chromoanagenesis) representing one
tail of the distribution of SV complexity and size. While
still rare, our data confirm that non-tumorigenic chro-
moanagenesis exists as both constitutional and somatic
Fig. 5 Extreme chromoanagenesis manifests by multiple mutational mechanisms in three participants with developmental anomalies. We applied
WGS to resolve microscopically visible cxSVs in three unrelated participants with developmental abnormalities. a, b Circos representations of two
cases of extreme and largely balanced chromothripsis, involving > 40 breakpoints, > 40 Mb, and > 12 genes across four chromosomes [9, 115].
Points plotted around the inner ring represented estimated copy number alterations; deletions are highlighted in red. Links represent non-
reference junctions on derivative chromosomes. c Circos representation of a somatic mosaic chromoanasynthesis event of chromosome 19 [115].
Duplications are shaded in blue and interspersed duplications are designated by shaded ribbons leading from the duplicated sequence to their
insertion site. d CMA and WGS analysis of the mosaic chromoanasynthesis from panel c (participant TL009) revealed all nine CNVs involved in the
rearrangement to have arisen on the maternal homologue and that 6/8 duplications were apparently mosaic (2.57 ± 0.02 copies, 95% CI; median
coverage shown in yellow; yellow shading indicates 95% CI). Surprisingly, 2/8 duplications (outlined in teal) exhibited significantly greater copy
numbers than the other six (p = 9.18 × 10–8), were linked by an underlying interstitial inversion and appeared to represent approximately three
copies, suggesting this rearrangement might have originated as a de novo dupINVdup cxSV in the maternal germline (Additional file 2: Figure S7)
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variation and that cytogenetically detected de novo inter-
chromosomal insertions may hallmark such extreme re-
arrangements, though larger collections of samples are
warranted to further investigate this phenomenon. The
review of chromoanagenesis literature performed herein
[10, 13, 17–23, 76–78] (Table 1 and Additional file 2:
Table S6) supports three conclusions: (1) constitutional
chromoanagenesis is frequently balanced, possibly due
to embryonic selection against loss of genes intolerant to
haploinsufficiency [79–81]; (2) extreme genomic rear-
rangements can be tolerated in the developing germline
[77, 78], although cases of unbalanced extreme chro-
moanagenesis have mostly been reported in cancer; and
(3) at least 2/55 of these rearrangements appeared to be
the product of multiple compounding mutational events
[23] and another 4/55 rearrangements were observed to
acquire additional rearrangements de novo upon unstable
transmission from parent to child [23, 77], suggesting it is
unlikely that such catastrophic rearrangements always
arise in a single mutational event. This latter conclusion
draws a key parallel between the two prevailing proposed
mechanisms of cancer chromoanagenesis, wherein some
rearrangements likely arise from DNA shattering in misse-
gregated micronuclei during mitosis [12, 54, 82–85], yet
others acquire additional breakpoints over punctuated
tumor evolution [14, 79, 86], not unlike the six constitu-
tional rearrangements with some degree of evidence
against a singular mutational event [23, 77].The mosaic
chromoanasynthesis characterized in this study may be an
exemplar of such mutational progression, as two of the
largest duplications appeared to represent germline dupli-
cations (copy state ~ 3), whereas the remaining rearrange-
ments were present at lower mosaic fractions (copy state
~ 2.5), possibly indicating progressive mutational acquisi-
tion. Further study into the mechanisms of such
alterations, and comparisons to the micronuclei hypoth-
esis, would be of great interest in our evolving under-
standing of this phenomenon.
Conclusions
This study provides new insights into the extensive and
diverse subclasses of SVs in the morbid human genome
and illuminates that inversion variation is substantially
more complex than has been appreciated from other
technologies. The patterns of variation defined here
extend previous maps of SVs in the general population
[1, 24], and functional annotations of the SVs in this
cohort demonstrate that rare SVs are more likely than
common SV to disrupt both coding and regulatory non-
coding elements. These analyses further suggest that
genes truncated by rare SV are more likely to be con-
strained against inactivating point mutations in healthy
individuals and associated with disease phenotypes in
large clinical databases. The presentation of three cases
of chromoanagenesis further support earlier evidence
that extremely complex balanced rearrangements are
tolerated in the human germline, and suggest that some
catastrophic constitutional rearrangements may arise
through multiple mutational events. This study empha-
sizes the need for detailed characterizations of SVs to aid
in interpretation of the morbid human genome, and these
data provide a reference map of inversions and cxSVs to
be built upon by population-scale sequencing studies.
Methods
Sample selection and phenotyping
Samples included in genome-wide analyses (n = 686)
were acquired from the SSC, a cohort of 2591 simplex
autism families, each with one affected child, one or
more unaffected siblings, and two unaffected parents
collected from 12 sites across the United States [44]. We
randomly selected 230 unrelated SSC probands, and se-
lected the remaining 456 on the basis of no known
pathogenic de novo gene-truncating point mutation or
large de novo CNV from prior whole exome sequencing
(WES) and CMA analyses [36]. All probands selected
from the SSC met standardized diagnostic criteria be-
tween the ages of four and 16 years for ASD and often
one or more additional neurodevelopmental anomalies,
which in this study included developmental delay
(60.7%), intellectual disability (31.6%), and seizures
(12.3%). Phenotype information for each sample was
previously ascertained by the SSC investigators (see
“Acknowledgements”) and we obtained these data with
permission through the online SFARIbase portal (http://
sfari.org/resources/sfari-base). DNA was obtained through
SFARI from the Coriell Cell Repository at Rutgers Univer-
sity (Camden, NJ, USA). The three cases with cytogeneti-
cally detected de novo translocational insertions were
referred by the University of Torino (Italy), the Columbia
University Medical Center (USA), and the UCLA Clinical
Genomics Center (USA) based on cytogenetic findings
from G-banded karyotyping. Informed consent was ob-
tained for all patients (either during collection by the SSC
or at the referring sites) and all samples (except UTR22)
were sequenced with approval from the Partners Health-
care Institutional Review Board. Ethical approval for
sequence analysis of case UTR22 was given by the ethical
committee of the San Luigi Gonzaga University Hospital-
Orbassano (TO) Italy.
liWGS library preparation and sequencing
Custom liWGS libraries were constructed using our
previously published protocols for all samples except
case UTR22, the protocol for which is described below
[42, 43]. One library was prepared and sequenced per par-
ticipant, and in a subset of 22 participants, we prepared
two separate libraries as technical replicates to evaluate
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the replicability of our computational methods. This re-
sulted in a total of 711 libraries included in this study. Li-
braries were quantified by the PicoGreen assay and
sequenced on either an Illumina HiSeq 2000 or 2500 plat-
form with 25 bp paired-end chemistry at the Broad Insti-
tute (Cambridge, MA) or the Massachusetts General
Hospital (MGH). Library barcodes were demultiplexed
per Illumina’s stated best practices. Reads failing Illumina
vendor filters were excluded. Read quality was assessed
with FastQC v0.11.2 (http://www.bioinformatics.babraha-
m.ac.uk). Reads were aligned to human reference genome
assembly GRCh37 (GCA_000001405.11) (http://apr2013.
archive.ensembl.org/Homo_sapiens) with BWA-backtrack
v0.7.10-r789 [87]. Duplicates were marked with SAM-
BLASTER v0.1.1 [88]. All alignment manipulation, includ-
ing sorting and indexing, was performed with sambamba
v0.4.6 [89]. Alignment quality was assessed using Picard-
Tools v1.115 (http://broadinstitute.github.io/picard/), Sam-
tools v1.0, and BamTools v2.2.2 [90, 91]. All libraries
were evaluated for sequencing and alignment quality on
numerous metrics, including mapped read pairs, per-
read and pairwise alignment rate, chimeric pair frac-
tion, haploid physical coverage, per-read and pairwise
duplicate rate, median insert size, and insert size me-
dian absolute deviation (MAD). All libraries except for
those generated from the three referred clinical cases
with large cytogenetic abnormalities were analyzed
genome-wide for the full mutational spectrum of SV,
the methods for which are described below.
Case UTR22 was recently described in a separate
study [9], but the sequencing protocols used for this case
are briefly restated here as follows: a liWGS library was
prepared using the Illumina mate-pair library kit. The
library was sequenced on an Illumina NextSeq using
paired 75 bp reads. The same DNA sample was also se-
quenced by paired-end siWGS on an Illumina HiSeq X
instrument (paired 151 bp reads). Reads were aligned to
the reference genome assembly GRCh37 using BWA-
0.7.5a [87]. SV discovery in the UTR22 siWGS library
was conducted using Manta with standard settings for
siWGS [92] and an independent custom pipeline for
liWGS [17].
lrWGS library preparation and sequencing
Prior to 10X Genomics lrWGS library construction, gen-
omic DNA samples were checked for fragment size
distribution and were quantified. Genomic DNA frag-
ment size distributions were determined with a Caliper
Lab Chip GX (Perkin Elmer) to quantify DNA above
40 kb in length. Size selection was performed on 1.2 ug
of genomic DNA with an 0.75% Agarose cassette on the
Blue Pippin platform (Sage Science) with target specifi-
cations set to start at 40 kb and end at 80 kb. Samples
were quantified using the Quant-it Picogreen assay kit
(Thermo Fisher) on a Qubit 2.0 Fluorometer (Thermo
Fisher) and normalized to a starting concentration of
1 ng/uL with TE (0.1 mM EDTA). Starting concentrations
of 1 ng/uL were confirmed by picogreen and libraries were
subsequently created in accordance with the 10X WGX
protocol (10X Genomics). Library size was determined
using the DNA 1000 Kit and 2100 BioAnalyzer (Agilent
Technologies) and quantified using quantitative PCR
(qPCR) (KAPA Library Quantification Kit, Kapa Biosys-
tems). The finished WGX libraries were run on an
Illumina HiSeqX platform at paired 151 bp reads with an
eight-base single index read at the Broad Institute. Upon
completion of sequencing, the resulting BCL files were
processed by the Long Ranger Pipeline (10X Genomics)
for alignment, variant discovery, and phasing.
Structural variation discovery from liWGS
A joint-calling consensus framework, Holmes, was devel-
oped for computational SV discovery optimized for
liWGS libraries. This pipeline involves the integration of
several SV signals simultaneously in batches of liWGS li-
braries. The codebase for this pipeline is open-source
and publicly available per details listed in “Availability of
Data and Materials.” We ran this SV discovery pipeline
on sequential batches of 278, 229, and 201 libraries and
merged the SV calls from each batch post hoc. For all
analyses, only the primary GRCh37v71 assembly was
considered and the mitochondrial chromosome was also
excluded. Although segments of this pipeline have been
described in previous publications [4, 5, 10, 37, 38, 43],
each stage is enumerated below.
Anomalous read-pair clustering algorithm
Non-duplicate pairs of primary alignments were first
clustered per library with our previously described
single-linkage read-pair clustering algorithms BAMStat
and ReadPairCluster at a minimum cluster size of three
pairs and a minimum clustering distance corresponding
to the library’s median insert size plus seven MAD [5,
10, 38]. The clustered read pairs were filtered to exclude
pairs in which both reads were multiply mapped (BWA
MapQ = 0), pairs where one or both reads mapped to
annotated somatic hypermutable sites (antibody parts;
“abParts”), and pairs where one or both reads mapped to
a set of genomic loci known to cause clustering bias in
paired-end WGS data adapted from a list compiled by
Layer et al. [93]. The remaining anomalous pairs from
the initial per-sample clustering were then pooled across
all samples and jointly clustered at a minimum cluster
size of three pairs and a minimum clustering distance of
the maximum clustering distance used for any individual
sample in each processed batch. These joint clusters
were heuristically classified with a decision tree algo-
rithm that modeled average mapping quality of the
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component read pairs, ratio of anomalous pairs in the
cluster to proper pairs spanning the same interval as the
read-pair cluster, ratio of anomalous pair coverage at the
putative breakpoint as compared to the median haploid
physical coverage of the library, uniqueness of read map-
ping positions, and maximum span of reads on either
side of the putative breakpoint. Thresholds for this deci-
sion tree were trained on known valid and invalid break-
points as determined by previous molecular validation
[4, 5]. Each cluster was categorized based on its SV
signature: deletion, insertion, inversion, or translocation.
These paired-end mapping signatures have been previ-
ously described [3, 43, 94]. Hybrid clusters representing
two proximal independent variants were separated post
hoc via assessment of non-overlapping subgrouping
spans between individual samples.
Physical sequencing depth algorithm
In parallel with our cluster-based analysis, we also inves-
tigated read depth across our cohort using a version of
the cn.MOPS algorithm modified to accommodate
liWGS data. This modification begins by dividing the
genome into 1 kb bins and counts the number of prop-
erly aligned read pairs whose insert spans each bin (i.e.
approximate binned physical coverage), rather than
counting the raw number of reads per bin, which is the
default setting. cn.MOPS was then run on these 1 kb
binned values and further run at larger bin sizes of 3 kb,
10 kb, and 30 kb, which correspond to minimum call
sizes of 3 kb, 9 kb, 30 kb, and 90 kb, respectively. The
resultant CNV segments were merged across all four bin
size runs with BEDTools merge to preserve breakpoint
resolution while avoiding overly segmented CNV calls
[95]. Supplementing the genome-wide read-depth calling
provided by cn.MOPS, we developed a statistical
machine-learning framework for local copy state geno-
typing across all putative CNV intervals based on the
same physical depth of coverage matrix used in
cn.MOPS CNV discovery. Candidate CNV intervals and
their associated sample IDs were input into this geno-
typing algorithm and a unidirectional t-test was used to
evaluate the significance between normalized physical
coverage across samples predicted to harbor the CNV
and predicted reference samples. The power and per-
muted p value of the t-test were evaluated; we set
thresholds of 0.8 and 0.01, respectively, for being suffi-
ciently powered and statistically significant to effectively
discriminate alterations in copy state between the two
groups of libraries (predicted CNV carriers and pre-
dicted diploid/reference samples). For singleton CNVs,
as well as sites with insufficient power (<0.8), a single
sample z-test was used per individual library and re-
quired p ≤ 1 × 10–6 for a non-reference copy number
assignment; this threshold was adjusted to p ≤ 1 × 10–4 if
the diploid cluster standard deviation was particularly
noisy (>0.1). Male and female samples were segregated
for all depth-based CNV analyses on allosomes.
Consensus categorization of canonical CNVs
Canonical CNVs (i.e. CNVs with no additional complex-
ity beyond deletion or tandem duplication) were catego-
rized by a tiered consensus framework to integrate
depth-based CNV segments with paired-end clusters
(Additional file 2: Figure S8). CNV sites were first nucle-
ated on the presence of paired-end clustering support.
Next, all cn.MOPS CNV intervals were merged across
all samples simultaneously by clustering 5’ and 3’ break-
points on proximity independently at a maximum dis-
tance of 10 kb per breakpoint between overlapping CNV
intervals. The mean breakpoint coordinate was taken
when two or more intervals were merged by this ap-
proach. These non-redundant cn.MOPS intervals were
then overlaid atop paired-end clusters by BEDTools
intersect requiring 50% reciprocal overlap and at least
one sample shared between both calls, with any
cn.MOPS intervals meeting these criteria being merged
into the paired-end clusters. In this instance, the union
of samples between cn.MOPS and paired-end clustering
calls was used and the breakpoint coordinates from the
paired-end clusters were retained, since short-read pair-
wise mappings have finer breakpoint resolution (generally
< 1 kb; improves with increased number of observations)
than depth-based CNV segmentation (generally ≥ 3 kb) in
our approach. When overlap was found between a
cn.MOPS interval and a paired-end cluster, the fraction of
overlapping samples between these two calls was re-
corded. Any cn.MOPS interval that did not match a
paired-end cluster was treated as an independent CNV
interval for the remainder of the consensus CNV pipeline.
At this stage, all putative CNVs were copy-state genotyped
in all samples as described above, with CNV genotypes be-
ing used to affirm or refute a putative CNV call. Finally, all
resultant CNV calls were intersected using BEDTools
coverage against a blacklist compiled of annotated dis-
persed multicopy loci (e.g. segmental duplications/low-
copy repeats), annotated heterochromatin, known sites of
systematic short-read mappability biases [93], and gaps in
the reference assembly; any CNV covered ≥ 30% by size by
these intervals was marked as less reliable due to the
underlying genomic context (a.k.a. “blacklisted”) [95].
CNVs were assigned a qualitative confidence score (high,
medium, or low) based on the above filters (see Additional
file 2: Figure S8), and only high-confidence and medium-
confidence CNVs were considered for genome-wide ana-
lyses. Low-confidence CNVs were recorded and retained
for future follow-up studies but were not included in any
analyses presented in this manuscript.
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Resolving cxSV sites
All candidate instances of cxSVs (i.e. variants involving
two or more different distinct SV signatures or three or
more breakpoints) were linked if at least one side of two
or more paired-end cluster putative breakpoints were
separated by no more than the joint clustering distance
used in that batch of libraries and involved a cluster
shared by at least one sample, or if the clusters were two
opposing unmated breakpoints (e.g. a candidate inver-
sion junction with only 5’/5’ oriented read pairs and a
second candidate inversion junction with only 3’/3’ ori-
ented read pairs) whose separating distance either over-
lapped with a cn.MOPS CNV segment in at least one
shared sample (via BEDTools intersect, reciprocal overlap
50% required) or was otherwise the only parsimonious
resolution for both breakpoints after manual scrutiny of
both unmated clusters and all discordant individual read
mappings near the unresolved breakpoints. All putative
complex SV sites were subsequently categorized by a cus-
tom shell script. Complex SV subclasses that could be
automatically resolved by this process included all combi-
nations of CNV-flanked inversions (delINV, INVdel,
dupINV, INVdup, delINVdel, dupINVdup, delINVdup,
dupINVdel), interspersed duplications (iDUP and iDUP-
del), and inverted tandem repeats (IR). All computation-
ally predicted complex variants were then manually
inspected and revised if necessary. All remaining unre-
solved putative complex sites were manually investigated
where there was evidence of at least six anomalous read-
pairs in support per sample, the event appeared in less
than 30% of all libraries, or the event featured overlapping
paired-end clustering and read-depth CNV segments. All
sites unable to be resolved manually or computationally
were emitted from the overall SV pipeline as incompletely
resolved sites (IRS).
SV callset curation
All SV calls output by Holmes were subjected to manual
inspection to ensure a high-confidence final SV callset. All
canonical inversions ≥4 kb, translocational insertions ≥
4 kb, canonical CNVs ≥ 100 kb, chromosomal transloca-
tions, and cxSV were evaluated. Manual inspections con-
sisted of assessing read pair clusters on mapping quality,
plotting read-pair mapping coordinates, and—where
applicable—visualizing normalized physical sequencing
depth with CNView at predicted sites of increased or de-
creased copy number, resulting in visual confirmation of
the proposed structure in >95% of manually inspected ob-
servations [96]. Second, since all liWGS libraries were pre-
pared from lymphoblastoid cell line (LCL)-derived DNA,
we screened our SV callset for large LCL passaging arti-
facts. We required all unbalanced SVs ≥ 100 kb with less
than 30% coverage by size of our CNV blacklisted regions
(see above) that appeared in 1/686 participants to have at
least one source of orthogonal validation performed on
whole blood-derived DNA (most commonly CMA; see
section on SV breakpoint validation, below), resulting in
an estimated 26 LCL artifacts that were not present in the
blood DNA. We also excluded any balanced rearrange-
ments validated in LCL-derived DNA but not in whole
blood-derived DNA due to likely being LCL passaging
artifacts (n = 2). It is likely that a comparable subset of
smaller SVs observed in this study (< 100 kb) may also be
LCL artifacts; however, given the high concordance of the
callset when compared to two independent sources of val-
idation from whole blood-derived DNA (see “SV break-
point validation” below), we do not anticipate remaining
LCL artifacts to be numerous.
Callset merging across sequencing batches
SV callsets from each batch of liWGS libraries (referred
to hereafter as “set 1” (n = 278), “set 2” (n = 229), and
“set 3” (n = 201), respectively) were merged using an it-
erative approach as follows. First, a list of non-
redundant SV breakpoints was linked between sets.
Breakpoints were linked if their mapping spans had at
least 20% overlap between sets and their predicted SV
type was concordant. Where multiple breakpoint clus-
ters were putatively linked from within the same set,
clusters were preferentially selected if they were classi-
fied as “Valid” by our heuristic classifier (see above), then
ranked by differences in variant allele frequency from
the original breakpoint, selecting the top match among
this list from each set. Each breakpoint from each set
was only allowed to correspond to one non-redundant
merged breakpoint, and each non-redundant merged
breakpoint could contain at most one breakpoint from
each set. The union of samples represented by all linked
clusters was taken to create the consolidated list of
unique subjects represented in each non-redundant
breakpoint cluster. We scrutinized the outcome of
this breakpoint linking procedure and identified only
2 total sites (0.01% of all SVs; 1 cxSV and 1 INS)
where two similar SVs were not merged into a single
consensus variant based on proximal breakpoint coor-
dinates (Collins2017_INS_459 & Collins2017_INS_460;
Collins2017_cxSV_213 & Collins2017_cxSV_214; see
Additional file 1). Next, any canonical CNV segments
not linked based on read-pair clustering as described were
further considered for linking between sets based on re-
ciprocal overlap ≥ 50% by size with another canonical
CNV segment from a different set. Where multiple canon-
ical CNV segments were eligible for linking from a single
set, the CNV with the greatest reciprocal overlap with the
original segment was selected. CNV confidence was reas-
signed to the merged non-redundant CNV segments
based on the highest confidence of any contributing CNV.
For all analyses, we excluded canonical CNVs designated
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as low-confidence (n = 6660; not included in any counts
reported in “Results,” “Discussion,” figures, tables, or
supplement).
SV validation experiments
We employed five approaches for validation of SVs de-
tected in this cohort, as detailed below.
PCR cloning and sanger sequencing
SV validation was performed on 144 SVs with traditional
PCR cloning and Sanger sequencing. Primers for break-
point cloning and Sanger sequencing were designed with
Primer3 run at default parameters [97]. Candidate primers
were further screened for degenerate hybridization and
non-specific product via BLAT and in silico PCR [98].
Primers were synthesized by Integrated DNA Technolo-
gies Inc. (Coralville, IA, USA). PCR products were visual-
ized by gel electrophoresis. Sanger sequencing was
conducted by GeneWhiz Inc. (South Plainfield, NJ, USA)
and the MGH DNA Core (Boston, MA, USA). Sequence
alignment was resolved using UCSC BLAT [98]. PCR and
Sanger resequencing was performed for a subset of break-
points from cases TL009, TL010, and UTR22, but these
validation experiments were not included for any perfor-
mances estimates per the genome-wide SV analyses.
CMA analysis
CNV detection from SNP CMA was previously performed
on 99.0% (679/686) of sequenced subjects used in
genome-wide SV analyses, which has been previously
described in detail [36, 99]. In brief, genotyping was per-
formed with the Illumina Omni2.5, 1Mv3, or 1Mv1 arrays.
CNVs were detected with the CNVision algorithm, which
calculates a joint probability for a variant based on three
methods (PennCNV, QuantiSNPv2.3, and GNOSIS) [36,
100, 101]. For the purpose of our analysis, we selected un-
balanced SVs most likely to be detected at CMA reso-
lution and thus restricted to the 1170 autosomal SVs with
at least one segment of predicted dosage imbalance ≥
40 kb that also did not have ≥ 30% coverage by size with
regions of known dosage biases or low-complexity se-
quences included in our blacklist used during CNV detec-
tion, as described earlier. We assessed overlap between
CMA-based CNV segments and our predicted intervals of
dosage imbalance from liWGS using BEDTools requir-
ing ≥ 50% coverage by size from CMA CNV calls over the
predicted liWGS CNV interval [95]. We considered any
SVs with at least one segment of dosage imbalance consid-
ered in this analysis that validated in at least one expected
sample to represent a true positive SV call.
Capture sequencing and analysis
Multiplexed high-throughput validation was conducted
by simultaneous breakpoint capture sequencing of 427
predicted SV sites across 96 child–parent trios (288 indi-
viduals). Breakpoints were selected to represent all pos-
sible SV classes; priority was given to rare variants, those
predicted to disrupt genes of interest, and those that did
not already have orthogonal validation from CMA ana-
lysis or PCR and Sanger sequencing at the time of the
capture validation experiment. Targeted capture probes
were tiled across 2250 bp, flanking both sides of each
breakpoint; probe density was progressively concen-
trated nearest the expected position of the breakpoint to
maximize sequencing depth crossing and directly flank-
ing predicted breakpoints. Degenerate probe sequences
(i.e. probes with multiple possible hybridization sites in
the reference genome) were identified by a combination
of the Jellyfish k-mer counting algorithm and in silico
probe sequence alignment with BWA-mem; all degen-
erate probes were removed from the capture design
[102, 103]. Library capture enrichment was performed
using the Agilent (Santa Clara, CA, USA) SureSelect
XT system and protocols. Ninety-six pools of three
samples were prepared, where each pool contained
the DNA from one participant, an unrelated mother,
and an unrelated father, where all three individuals in
the pool were not predicted to share any breakpoints
present in the capture design. These 96 pools were
barcoded, multiplexed, and sequenced once with a full
lane of single-end 101 bp reads and once with a full
lane of paired-end 101 bp on an Illumina HiSeq 2500
at the Broad Institute (Cambridge, MA, USA). Two
sets of 12 pools received additional sequencing at
single-end 150 bp and single-end 300 bp on the Illu-
mina MiSeq platform at MGH to test the effect of
longer read lengths in this capture design. Sequencing
data were processed as described previously for
liWGS libraries. Across all 96 capture libraries, a total
of 6.23 billion reads were generated. Sequences cross-
ing putative SV breakpoints (and thus overall SV val-
idity) were obtained by blindly screening all capture
data for high-quality individual non-duplicate reads
with a primary alignment flanking one side of the
predicted breakpoint and a secondary or supplemen-
tary alignment flanking the other side of the predicted
breakpoint. All candidate split-read sequences were
evaluated manually using BLAT to ensure they did
not have any equally parsimonious alignments any-
where else in the genome [98]. A subset of break-
points showed paired-end clustering support without
a split read, which we included if they showed a sta-
tistically significant enrichment of paired-end reads
relative to predicted reference samples.
liWGS versus siWGS overlap
We evaluated the overlap between SV calls from the 39
participants for which previously generated siWGS data
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were available [104]. We considered two approaches for
validating liWGS SV calls from siWGS data. For all com-
pletely resolved liWGS SV calls (i.e. excluding IRS) appear-
ing in at least one of the 39 participants with near-
breakpoint precision (i.e. any call with at least one cluster
of anomalous liWGS read pairs; n = 2399), we searched
that participants’ corresponding siWGS library within a
window of ±5 kb from the liWGS-predicted breakpoint
coordinates for any anomalous, non-duplicate, primary
aligned siWGS pairs mapping to within the 5 kb windows
of the predicted breakpoint. Further, we required the
aligned orientation of siWGS pairs to match those of the
corresponding liWGS pairs. Windows of 5 kb were chosen
as the upper bound of conceivable breakpoint imprecision
from liWGS alone. Any SV with one breakpoint supported
by ≥ 3 unique siWGS read pairs meeting our criteria in at
least one expected sample was considered a true positive
liWGS call. When comparing siWGS data against our pre-
dicted “invalid” clusters of anomalous liWGS read pairs to
estimate false negative rates, we conservatively relaxed
these thresholds to ±7.5 kb and ≥ 1 unique siWGS read
pair. Second, we evaluated evidence from siWGS sequen-
cing depth for all completely resolved (i.e. excluding IRS)
autosomal liWGS SV calls appearing in at least one of the
39 participants with at least one interval of dosage imbal-
ance ≥ 10 kb that had < 30% coverage by our blacklisted
CNV loci (n = 585; 514 of which also were considered dur-
ing siWGS read-pair analysis). For this analysis, we first
ran cn.MOPS on siWGS libraries for all 39 participants
and their families (mothers, fathers, and one sibling each)
from available data [104, 105]. Similar to our application of
cn.MOPS during liWGS SV discovery (see above), we ran
cn.MOPS on this siWGS dataset at bin sizes of 100 bp,
300 bp, 1 kb, and 3 kb, resulting in minimum CNV call
sizes of 300 bp, 900 bp, 3 kb, and 9 kb, respectively. We
merged the resultant calls per sample across these three
bin sizes to obtain an initial set of depth-based CNV calls
for comparison versus liWGS. For each interval of dosage
imbalance from liWGS that met our criteria for this ana-
lysis, we evaluated coverage of that interval against siWGS
cn.MOPS calls from that same participant. Any liWGS call
with an interval of ≥ 50% coverage by siWGS cn.MOPS
calls in at least one expected sample was considered a true
positive liWGS SV call. The total number of non-
redundant SVs considered by either read-pair or sequen-
cing depth analyses versus siWGS was 2470.
liWGS sensitivity analysis versus CMA CNVs
We evaluated the sensitivity of liWGS for detection of
high-confidence CNVs reported by CMA. As the reso-
lution of CMA is variable across the genome (for ex-
ample, based on the probe density at a given locus), we
applied filters to the raw CNV calls from CMA on the
subset of 99.0% of participants in this study for which
CMA CNVs had previously been reported [36, 99]. We
thus required CMA CNV calls to be ≥ 25 kb, have < 30%
coverage by size versus the CNV blacklist applied during
liWGS SV discovery, and have a pCNV ≤ 1 × 10–9 as
required by the published methods for CMA CNV
analyses in these same participants by Sanders et al.
[36, 99]. For each CMA CNV meeting these criteria,
we compared the CNV interval to the predicted intervals
of dosage imbalance from fully resolved liWGS SV calls
(including canonical CNVs and also unbalanced cxSVs).
We considered a CMA CNV to be successfully detected
by liWGS if the CMA CNV interval had ≥ 25% coverage
by size from regions of dosage imbalance from that partic-
ipant’s corresponding liWGS SVs. We did not observe
major differences in the outcome when requiring different
stringencies of reciprocal overlap (up to ~75%).
liWGS technical replicate analysis
For 22 participants, we sequenced pairs of technical
replicate liWGS libraries to assess the consistency of
our SV discovery methods, as described above. Given
that pairs of technical replicates varied in coverage,
and since depth of coverage can bias sensitivity in
many variant detection applications [106], we desig-
nated the replicate with fewer total fully resolved SV
calls in each pair as the truth library and the second
replicate as the test library. For each pair, we evalu-
ated concordance of SV calls as the total number of
fully resolved SVs from the truth library detected in
the test library divided by the total number of fully
resolved SVs in the truth library.
Comparison to other studies and SV reference databases
We downloaded SV callsets as reported in six recent
WGS studies of SV outside the SSC [1, 5, 7, 46–48] and
two public SV reference databases [49, 50]. We next
decomposed each callset into sets of genomic intervals
representing deletion, duplication, inversion, and inser-
tion. For studies where cxSVs were reported as multiple
intervals (e.g. a delINVdel reported as two deletion in-
tervals and one inversion interval), we separated those
intervals into their respective categories prior to com-
parisons. For studies where cxSVs were reported only as
one single interval with no additional information, we
treated that interval as a composite complex interval for
sake of comparisons. For classes of SV reported that did
not fit into any of these previous categories, we added
them to a final “other” SV category. From these cleaned
callsets, we compared each of the SVs identified in this
study to its respective SV category as well as the “other”
SV category. For cxSVs, we compared each rearranged
interval identified in our study to its respective category
and also compared the entire interval spanned by the
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cxSV to the complex and “other” categories. We deter-
mined two intervals to be concordant if they shared 50%
reciprocal overlap by size per BEDTools intersect. cxSVs
were considered successfully matched in their entirety if
all intervals involved in the rearrangement as identified
by liWGS in this study had a matching interval in the
comparison datasets. If one or more intervals involved
in a cxSV were not matched in any of the reference
datasets, we considered that cxSV to have been previ-
ously discovered but incompletely characterized.
Evaluating the relationship between inversion
breakpoints and long repetitive sequences
We first annotated all inverted loci involved in complex
and canonical SVs excluding insertions against annotated
repetitive sequences at least 300 bp in length from
RepeatMasker and the UCSC segmental duplication
track for human assembly GRCh37 [61, 107]. As liWGS
does not provide nucleotide-level precision of break-
points, and instead usually offers a breakpoint resolution
of ~1.5 kb, we drew a conservative window of ±500 bp
around each predicted inversion breakpoint and inter-
sected against the set of repetitive elements described
above using BEDTools intersect while requiring at least
one base of overlap [95]. We next shuffled all inversion
intervals across the GRCh37 reference genome with
BEDTools shuffle, and did not allow breakpoints to be
placed in N-masked reference sequences to avoid artifi-
cially depleting our simulated inversions from mappable
regions of the genome. Importantly, for each simulated
set of inversions, we maintained the original size distri-
bution of inversions derived from the experimental
liWGS data. We next repeated the repetitive sequence
annotation process for each set of simulated inversions,
and calculated empirical p values by comparing our ob-
served values against all simulated values. We calculated
p values for all repeat elements in aggregate, but also
considered the four most common repeat families inde-
pendently: SINEs, LINEs, LTRs, and segmental duplica-
tions (Seg. Dup.). Finally, we adjusted p values for
multiple comparisons using a Benjamini–Hochberg
correction.
Genome-wide SV enrichment tests
To assess our callset for the presence of loci enriched in
SV beyond random chance, we first segmented the
GRCh37 reference genome into 100 kb contiguous bins.
We next removed all bins that had at least 10% covered
by the CNV mask applied during SV detection to avoid
observing artificially depleted bins due to technical limi-
tations. We further restricted this analysis to autosomes.
We then overlaid all SVs discovered in this cohort atop
the remaining bins (n = 24,742) and counted the number
of SVs per bin. We tabulated counts per bin for all fully
resolved SVs (i.e. excluding IRS) as well as counts spe-
cific to each major SV class except IRS (DEL, DUP, INS,
INV, CTX, cxSV). We next made the null assumptions
that large SVs are (1) rare events in the genome (as com-
pared to SNPs or InDels) and (2) that they should follow
a random distribution across the genome. Given that
these assumptions fit the description of a Poisson point
process, similar to the observation of sequencing reads
by Lander and Waterman [108], we thus evaluated a
Poisson test (λ =mean count of SVs per bin) for the
count of SVs per bin to evaluate the alternative hypoth-
esis of enrichment of SVs at the tested loci beyond ex-
pectation (e.g. hypermutable or repeatedly rearranged
loci). We subsequently applied the Benjamini–Hochberg
procedure to control FDR and assessed genome-wide
significance at q ≤ 0.05. Finally, where multiple 100 kb
bins each emerged as significantly enriched for SVs be-
yond expectation and were not separated by more than
a single non-significant 100 kb bin, we merged those
bins into one larger locus and assigned the maximum p
value of any one sub-bin to the larger locus.
Gene annotation
All completely resolved SVs (i.e. excluding IRS) were
evaluated for possible genic overlap by breakpoint com-
parison with all annotated transcripts from the Ensembl
gene annotation GTF for hg19/GRCh37 [109]. Intersec-
tions were performed with BEDTools intersect for
single-breakpoint variants and BEDTools pairtobed for
mutli-breakpoint variants [95]. Deletions were classified
as LoF if they altered at least one base from any anno-
tated exon. Duplications were classified as LoF if they
duplicated one or more bases from any annotated in-
ternal exon (i.e. neither the 5’ UTR, 3’ UTR, first exon,
or last exon) without spanning beyond the first or last
exon of the gene and were classified as whole-gene copy
gain (CG) if the duplication encapsulated an entire an-
notated transcript. Inversions were classified as LoF if
one breakpoint localized to an annotated transcript and
the other breakpoint localized outside that transcript or
if both breakpoints lay within the same transcript and
the interval between the two breakpoints spanned at
least one annotated exon. Translocations were consid-
ered LoF if either breakpoint lay within an annotated
transcript. Given that the resolution of liWGS did not
permit exact breakpoint base-pair-scale mapping, we did
not consider insertions for LoF or CG gene impacts, but
did make note if inserted sequence originated from a gene
or if sequence was being inserted into a gene. Complex
events were annotated by first decomposing the variant
into its constituent SV signatures, then interpreting each
SV signature simultaneously with the methodology de-
scribed above to reach a consensus on the overall genic
impact of the rearrangement. All interpretation of genic
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impact was constructed on a transcript-specific basis for
each transcript overlapped by each variant. Where rele-
vant, specific gene lists were adopted by those curated by
the laboratory of Daniel MacArthur, which are available
online (https://github.com/macarthur-lab/gene_lists).
Non-coding or positional functional effect annotation
All SVs were evaluated for potential non-coding or pos-
itional functional effects. Any SV with breakpoints in
two different topologically-associated domains (TADs)
per annotations by Dixon et al. were recorded as pos-
sibly having a disruptive effect on the regulation of any
gene encompassed by the disrupted TAD(s) [110]. Fur-
ther, all SVs were overlaid atop ENCODE promoter and
enhancer annotations from all histone marks (H3K27ac,
H3K4me1, H3K4me3, HeK9ac) as previously reported
by the ENCODE consortium [111, 112]. Per ENCODE
recommendations available on the ENCODE website
(https://www.encodeproject.org/), promoter regions
were derived by merging histone marks H3K4me3
and H3K9ac, while enhancer regions were derived by
merging histone marks H3K27ac, H3K4me1, and
H3K9ac. Deletions and duplications were annotated
for any overlap with a promoter or enhancer, while at
least one breakpoint from an insertion, inversion, or
translocation had to lie within a promoter or enhan-
cer to be considered as potentially disruptive.
Scores of intolerance to LoF variation in healthy
individuals
Where available, we considered residual variation intoler-
ance scores (RVIS) and LoF constraint scores (pLI) for
each gene in the UCSC RefFlat for GRCh37 [66, 67, 107].
As previously described, pLI measures statistical depletion
of truncating (LoF) mutations in healthy individuals be-
yond what is expected by a model that estimates the back-
ground mutation rate of every possible trinucleotide
combination in the genome, while RVIS calculates the re-
sidual depletion of functional mutations (including both
LoF and missense) in healthy individuals per gene beyond
what is expected by chance [66, 67]. We used the pLI and
RVIS scores from the data released circa 2015 summer
corresponding to the data published on 60,706 individuals
by the Exome Aggregation Consortium [65]. Per specifica-
tions of both groups of authors, we considered a gene to
be intolerant to/constrained against functional mutation if
it had an RVIS score ≤ 10.0 or a pLI ≥ 0.90.
Real-time quantitative PCR of MBD5 and ACVR2A
transcripts
RNA was extracted from 106 LCL cells, obtained
through SFARI from the Coriell Cell Repository at
Rutgers University (Camden, NJ, USA), from the
participant harboring the de novo 675 kb inversion at
the 2q23.1/MBD5 microdeletion locus and two unre-
lated individuals selected as controls: one affected and
an unaffected mother unrelated to either selected par-
ticipant. Extractions were performed using TRIzol
(Invitrogen) followed by RNeasy kit (Qiagen) column
purification. First-strand complementary DNA (cDNA)
was synthetized using Verso cDNA Synthesis Kit
(ThermoFisher Scientific) from 1 ug of total RNA
with oligo(dT), random hexamers, and RNase inhibi-
tor. Real-time quantitative PCR (RT-qPCR) was then
performed for messenger RNA expression of MBD5
and ACVR2A as well as ACTB as an endogenous con-
trol with the following primer sequences:
ACVR2A (exons 2-4, forward): 5′
CTG GTG TTG AAC CGT GTT ATG 3′
ACVR2A (exons 2-4, reverse): 5′
GAT TTG AAG TGG GCT GTG TG 3′
ACVR2A (exons 5-6, forward): 5′
GTT ACA CCT AAG CCA CCC TAT TAC 3′
ACVR2A (exons 5-6, reverse): 5′
GCT TTC CAG ACA CAA CCA AAT C 3′
MBD5 (exons 3-4, forward): 5′
CAG ATG GCA ACA GAG GATG T 3′
MBD5 (exons 3-4, reverse): 5′
GCA GTG TAA TGG AGG CAG TT 3′
MBD5 (exons 7-8, forward): 5′
GTG GCT TGG AAT GTC CTC TT 3′
MBD5 (exons 7-8, reverse): 5′
TCT GCG GTT CTC TGT TTC AC 3′
ACTB (exons 5-6, forward): 5′
TGA AGT GTG ACG TGG ACA TC 3′
ACTB (exons 5-6, reverse): 5′
GGA GGA GCA ATG ATC TTG AT 3′
Primers and nuclease-free water were added to the
LightCycler® 480 SYBR Green I Master Mix (Roche).
All samples of cDNA (diluted 1:10) were run in tripli-
cate in final 20 uL reaction volumes. LightCycler® 480
equipment (Roche) was used followed by the manu-
facturer’s software for Ct calculation. Relative differ-
ences in transcript levels were quantified according to
the delta Ct method and normalized to ACTB. Stand-
ard error of the mean (SEM) was calculated for each
sample. Results are expressed as fold-change relative
to the endogenous control gene normalized to the
average of the two control samples.
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